Who are Progesterone Vaginal Gel with Applicator's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Norethisterone,Ethinylestradiol, mifegyne and cytotec, Progesterone Soft Capsules.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/progesterone-vaginal-gel-with-applicator.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Progesterone Vaginal Gel with Applicator — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Progesterone Vaginal Gel with Applicator (Progesterone Vaginal Gel with Applicator) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Progestogen. Area: Women's Health.

phase 3 Progestogen Women's Health Small molecule Live · refreshed every 30 min

Target snapshot

Progesterone Vaginal Gel with Applicator (Progesterone Vaginal Gel with Applicator) — IBSA Institut Biochimique SA. Progesterone acts as a steroid hormone that helps to maintain the pregnancy by preparing the uterus to implant a fertilized egg and supporting embryonic development.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Progesterone Vaginal Gel with Applicator TARGET	Progesterone Vaginal Gel with Applicator	IBSA Institut Biochimique SA	phase 3	Progestogen
Norethisterone,Ethinylestradiol	Norethisterone,Ethinylestradiol	Nobelpharma	phase 3	progestogen-estrogen combination	progesterone receptor, estrogen receptor
mifegyne and cytotec	mifegyne and cytotec	Western Galilee Hospital-Nahariya	phase 3	Antiprogestogen	Progesterone receptor
Progesterone Soft Capsules	Progesterone Soft Capsules	Changchun GeneScience Pharmaceutical Co., Ltd.	phase 3	Progestogen	Progesterone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Progestogen class)

Changchun GeneScience Pharmaceutical Co., Ltd. · 1 drug in this class
IBSA Institut Biochimique SA · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Progesterone Vaginal Gel with Applicator — Competitive Intelligence Brief. https://druglandscape.com/ci/progesterone-vaginal-gel-with-applicator. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab